# Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

> **NCT02433379** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 1173 (actual)

## Conditions studied

- Ventricular Fibrillation
- Ventricular Tachycardia
- Low Cardiac Output

## Interventions

- **DEVICE:** EMBLEM S-ICD System

## Key facts

- **NCT ID:** NCT02433379
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-09
- **Primary completion:** 2019-12-06
- **Final completion:** 2019-12-06
- **Target enrollment:** 1173 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433379, "Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02433379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*